Erratum: Sphingolipids: Agents provocateurs in the pathogenesis of insulin resistance (Diabetologia (2011) 54 (2969) DOI 10.1007/s00125-011-2127-3));Sphingolipids: Agents provocateurs in the pathogenesis of insulin resistance

Diabetologia

Volumn 54, Issue 7, 2011, Pages 1596-1607

  Lipina, C ^a   Hundal, H S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adipose tissue; Caveolae; Ceramide; Gangliosides; GM3; PKB Akt; Skeletal muscle; Sphingomyelin

Indexed keywords

AMITRIPTYLINE; CALCINEURIN; CERAMIDE; CYCLOSERINE; CYTOKINE; FUMONISIN B1; GANGLIOSIDE GM3; INSULIN; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE B; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C ZETA; SATURATED FATTY ACID; SPHINGOMYELIN PHOSPHODIESTERASE; THERMOZYMOCIDIN;

CAVEOLA; DIABETES MELLITUS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE ACTION; HUMAN; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 79959746261     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2286-2     Document Type: Erratum

References (100)

1. GL Dohm EB Tapscott WJ Pories, et al. 1988 An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects J Clin Invest 82 486 494 3403714 10.1172/JCI113622 1:CAS:528:DyaL1cXlsVOnsbs%3D
2. AV Greco G Mingrone A Giancaterini, et al. 2002 Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion Diabetes 51 144 151 11756334 10.2337/diabetes.51.1.144 1:CAS:528:DC%2BD38Xlt1ehsg%3D%3D (Pubitemid 34517991)
3. SI Itani NB Ruderman F Schmieder G Boden 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α Diabetes 51 2005 2011 12086926 10.2337/diabetes.51.7.2005 1:CAS:528:DC%2BD38Xlt1Wls7c%3D (Pubitemid 34729001)
4. DM Muoio 2010 Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim Biophys Acta 1801 281 288 19958841 1:CAS:528:DC%2BC3cXitVejtLk%3D
5. BH Goodpaster DE Kelley 2002 Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep 2 216 222 12643176 10.1007/s11892-002-0086-2
6. M Monetti MC Levin MJ Watt, et al. 2007 Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab 6 69 78 17618857 10.1016/j.cmet.2007.05.005 1:CAS:528:DC%2BD2sXotlCitLg%3D (Pubitemid 46995777)
7. JJ Dube F Amati M Stefanovic-Racic FG Toledo SE Sauers BH Goodpaster 2008 Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited Am J Physiol Endocrinol Metab 294 E882 888 18319352 10.1152/ajpendo.00769.2007 1:CAS:528:DC%2BD1cXlvFCrsLs%3D
8. E Hajduch GJ Litherland HS Hundal 2001 Protein kinase B (PKB/Akt)-a key regulator of glucose transport? FEBS Lett 492 199 203 11257494 10.1016/S0014-5793(01)02242-6 1:CAS:528:DC%2BD3MXhvVantL4%3D (Pubitemid 32217828)
9. EL Whiteman H Cho MJ Birnbaum 2002 Role of Akt/protein kinase B in metabolism Trends Endocrinol Metab 13 444 451 12431841 10.1016/S1043-2760(02) 00662-8 1:CAS:528:DC%2BD38XosFCmsrw%3D (Pubitemid 36733939)
10. M Roden TB Price G Perseghin, et al. 1996 Mechanism of free fatty acid-induced insulin resistance in humans J Clin Invest 97 2859 2865 8675698 10.1172/JCI118742 1:CAS:528:DyaK28XjvVWksLw%3D (Pubitemid 26197099)
11. M Roden M Krssak H Stingl, et al. 1999 Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans Diabetes 48 358 364 10334314 10.2337/diabetes.48.2.358 1:CAS:528:DyaK1MXpsFKmtA%3D%3D (Pubitemid 29061111)
12. B Vanhaesebroeck DR Alessi 2000 The PI3K-PDK1 connection: more than just a road to PKB Biochem J 346 Pt 3 561 576 10698680 10.1042/0264-6021:3460561 1:CAS:528:DC%2BD3cXit1Kku78%3D (Pubitemid 30171014)
13. CC Milburn M Deak SM Kelly NC Price DR Alessi DM Van Aalten 2003 Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change Biochem J 375 531 538 12964941 10.1042/BJ20031229 1:CAS:528:DC%2BD3sXotlehsro%3D (Pubitemid 37433501)
14. Y Liao MC Hung 2010 Physiological regulation of Akt activity and stability Am J Transl Res 2 19 42 20182580 1:CAS:528:DC%2BD1MXhsFyrurvN
15. JA Chavez TA Knotts LP Wang, et al. 2003 A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids J Biol Chem 278 10297 10303 12525490 10.1074/jbc.M212307200 1:CAS:528:DC%2BD3sXitVCrs7w%3D (Pubitemid 36800291)
16. WL Holland JT Brozinick LP Wang, et al. 2007 Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance Cell Metab 5 167 179 17339025 10.1016/j.cmet.2007.01.002 1:CAS:528:DC%2BD2sXjsF2qtL8%3D
17. C Schmitz-Peiffer DL Craig TJ Biden 1999 Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate J Biol Chem 274 24202 24210 10446195 10.1074/jbc.274.34.24202 1:CAS:528:DyaK1MXlsVOnurw%3D (Pubitemid 29390356)
18. T Teruel R Hernandez M Lorenzo 2001 Ceramide mediates insulin resistance by tumor necrosis factor-α in brown adipocytes by maintaining Akt in an inactive dephosphorylated state Diabetes 50 2563 2571 11679435 10.2337/diabetes.50.11.2563 1:CAS:528:DC%2BD3MXotFGis7s%3D (Pubitemid 33642775)
19. E Hajduch A Balendran IH Batty, et al. 2001 Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells Diabetologia 44 173 183 11270673 10.1007/s001250051596 1:CAS:528:DC%2BD3MXntlSltQ%3D%3D (Pubitemid 32156201)
20. S Stratford KL Hoehn F Liu SA Summers 2004 Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B J Biol Chem 279 36608 36615 15220355 10.1074/jbc.M406499200 1:CAS:528:DC%2BD2cXmvFCms78%3D (Pubitemid 39129005)
21. M Colombini 2010 Ceramide channels and their role in mitochondria- mediated apoptosis Biochim Biophys Acta 1797 1239 1244 20100454 10.1016/j.bbabio.2010.01.021 1:CAS:528:DC%2BC3cXnvV2ru7o%3D
22. RN Kolesnick M Kronke 1998 Regulation of ceramide production and apoptosis Annu Rev Physiol 60 643 665 9558480 10.1146/annurev.physiol.60.1.643 1:CAS:528:DyaK1cXitVOhsbg%3D (Pubitemid 28157890)
23. G Yang L Badeanlou J Bielawski AJ Roberts YA Hannun F Samad 2009 Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Am J Physiol Endocrinol Metab 297 E211 E224 19435851 10.1152/ajpendo.91014.2008 1:CAS:528:DC%2BD1MXovVKjtLo%3D
24. B Stancevic R Kolesnick 2010 Ceramide-rich platforms in transmembrane signaling FEBS Lett 584 1728 1740 20178791 10.1016/j.febslet.2010.02.026 1:CAS:528:DC%2BC3cXkvFKqur0%3D
25. JS Won YB Im M Khan AK Singh I Singh 2004 The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase J Neurochem 88 583 593 14720208 10.1046/j.1471-4159.2003.02165.x 1:CAS:528:DC%2BD2cXhtVaisbw%3D (Pubitemid 38140203)
26. AH Merrill Jr 2002 De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway J Biol Chem 277 25843 25846 12011104 10.1074/jbc.R200009200 1:CAS:528:DC%2BD38XlsFKrsrc%3D (Pubitemid 34967059)
27. R Bose M Verheij A Haimovitz-Friedman K Scotto Z Fuks R Kolesnick 1995 Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals Cell 82 405 414 7634330 10.1016/0092-8674(95)90429-8 1:CAS:528:DyaK2MXnsFSgsbY%3D
28. WC Liao A Haimovitz-Friedman RS Persaud, et al. 1999 Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase J Biol Chem 274 17908 17917 10364237 10.1074/jbc.274.25.17908 1:CAS:528:DyaK1MXktVylsLk%3D (Pubitemid 29283314)
29. ML Watson M Coghlan HS Hundal 2009 Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells Biochem J 417 791 801 18922131 10.1042/BJ20081149 1:CAS:528:DC%2BD1MXlvFOgug%3D%3D
30. YY Liu TY Han AE Giuliano N Hansen MC Cabot 2000 Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance J Biol Chem 275 7138 7143 10702281 10.1074/jbc.275.10.7138 1:CAS:528:DC%2BD3cXhvVGkurg%3D (Pubitemid 30146262)
31. MH Granado P Gangoiti A Ouro L Arana A Gomez-Munoz 2009 Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages Biochim Biophys Acta 1791 263 272 19416641 1:CAS:528:DC%2BD1MXjsVOisr8%3D
32. A Virkamaki E Korsheninnikova A Seppala-Lindroos, et al. 2001 Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle Diabetes 50 2337 2343 11574417 10.2337/diabetes.50.10.2337 1:CAS:528:DC%2BD3MXntlGhu7k%3D (Pubitemid 33641920)
33. CR Bruce AD Kriketos GJ Cooney JA Hawley 2004 Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes Diabetologia 47 23 30 14673522 10.1007/s00125-003-1265-7 1:CAS:528:DC%2BD2cXjsFeqsA%3D%3D (Pubitemid 38141936)
34. SA Summers LA Garza H Zhou MJ Birnbaum 1998 Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide Mol Cell Biol 18 5457 5464 9710629 1:CAS:528: DyaK1cXls1Sgurg%3D (Pubitemid 28388128)
35. DJ Powell S Turban A Gray E Hajduch HS Hundal 2004 Intracellular ceramide synthesis and protein kinase Cζ activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells Biochem J 382 619 629 15193147 10.1042/BJ20040139 1:CAS:528:DC%2BD2cXmvVOnt7k%3D (Pubitemid 39243928)
36. JA Chavez SA Summers 2003 Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes Arch Biochem Biophys 419 101 109 14592453 10.1016/j.abb.2003.08.020 1:CAS:528:DC%2BD3sXosVyhurc%3D (Pubitemid 37329976)
37. L Pickersgill GJ Litherland AS Greenberg M Walker SJ Yeaman 2007 Key role for ceramides in mediating insulin resistance in human muscle cells J Biol Chem 282 12583 12589 17337731 10.1074/jbc.M611157200 1:CAS:528:DC%2BD2sXksVSisro%3D (Pubitemid 47100630)
38. F Samad KD Hester G Yang YA Hannun J Bielawski 2006 Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk Diabetes 55 2579 2587 16936207 10.2337/db06-0330 1:CAS:528:DC%2BD28XpsVOru78%3D (Pubitemid 44871159)
39. A Blachnio-Zabielska M Baranowski P Zabielski J Gorski 2010 Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle J Cell Physiol 225 786 791 20568228 10.1002/jcp.22283 1:CAS:528:DC%2BC3cXhtFGqsL%2FJ
40. JM Adams 2nd T Pratipanawatr R Berria, et al. 2004 Ceramide content is increased in skeletal muscle from obese insulin-resistant humans Diabetes 53 25 31 14693694 10.2337/diabetes.53.1.25 1:CAS:528:DC%2BD2cXitlagtQ%3D%3D (Pubitemid 38044694)
41. M Straczkowski I Kowalska M Baranowski, et al. 2007 Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes Diabetologia 50 2366 2373 17724577 10.1007/s00125-007-0781-2 1:CAS:528:DC%2BD2sXhtFSlsL3M (Pubitemid 47512392)
42. J Turinsky BP Bayly DM O'Sullivan 1990 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin J Biol Chem 265 7933 7938 2186032 1:CAS:528:DyaK3cXitlSjur0%3D
43. JK Kim JJ Fillmore Y Chen, et al. 2001 Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance Proc Natl Acad Sci USA 98 7522 7527 11390966 10.1073/pnas.121164498 1:CAS:528:DC%2BD3MXkslWls7w%3D (Pubitemid 32567981)
44. CR Bruce AB Thrush VA Mertz, et al. 2006 Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content Am J Physiol Endocrinol Metab 291 E99 E107 16464906 10.1152/ajpendo.00587.2005 1:CAS:528:DC%2BD28XntFGitr8%3D (Pubitemid 44035314)
45. S Stratford DB DeWald SA Summers 2001 Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation Biochem J 354 359 368 11171115 10.1042/0264-6021:3540359 1:CAS:528:DC%2BD3MXitFWrsLc%3D (Pubitemid 32209874)
46. R Cazzolli L Carpenter TJ Biden C Schmitz-Peiffer 2001 A role for protein phosphatase 2A-like activity, but not atypical protein kinase Cζ, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate Diabetes 50 2210 2218 11574400 10.2337/diabetes.50.10.2210 1:CAS:528:DC%2BD3MXntlGhur4%3D (Pubitemid 33641903)
47. CE Chalfant K Kishikawa MC Mumby C Kamibayashi A Bielawska YA Hannun 1999 Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid J Biol Chem 274 20313 20317 10400653 10.1074/jbc.274.29.20313 1:CAS:528:DyaK1MXks1OjsLg%3D (Pubitemid 29340385)
48. CM Blouin C Prado KK Takane, et al. 2010 Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling Diabetes 59 600 610 19959757 10.2337/db09-0897 1:CAS:528:DC%2BC3cXjslegtLg%3D
49. RN Cortright JL Azevedo Jr Q Zhou, et al. 2000 Protein kinase C modulates insulin action in human skeletal muscle Am J Physiol Endocrinol Metab 278 E553 E562 10710511 1:CAS:528:DC%2BD3cXhvV2qurs%3D
50. NA Bourbon L Sandirasegarane M Kester 2002 Ceramide-induced inhibition of Akt is mediated through protein kinase Cζ: implications for growth arrest J Biol Chem 277 3286 3292 11723139 10.1074/jbc.M110541200 1:CAS:528: DC%2BD38XhtVaksLY%3D (Pubitemid 34953194)
51. DJ Powell E Hajduch G Kular HS Hundal 2003 Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCζ-dependent mechanism Mol Cell Biol 23 7794 7808 14560023 10.1128/MCB.23.21.7794-7808.2003 1:CAS:528:DC%2BD3sXosFOgt7k%3D (Pubitemid 37271476)
52. C Stretton A Evans HS Hundal 2010 Cellular depletion of atypical PKCλ is associated with enhanced insulin-sensitivity and glucose uptake in L6 rat skeletal muscle cells Am J Physiol Endocrinol Metab 299 E402 E412 20530734 10.1152/ajpendo.00171.2010 1:CAS:528:DC%2BC3cXht1Wgu7nO
53. E Hajduch S Turban X Le Liepvre, et al. 2008 Targeting of PKCζ and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide Biochem J 410 369 379 17983354 10.1042/BJ20070936 1:CAS:528:DC%2BD1cXhvVymtrc%3D (Pubitemid 351346195)
54. RP Doornbos M Theelen PC van der Hoeven WJ van Blitterswijk AJ Verkleij PM van Bergen en Henegouwen 1999 Protein kinase Cζ is a negative regulator of protein kinase B activity J Biol Chem 274 8589 8596 10085094 10.1074/jbc.274.13.8589 1:CAS:528:DyaK1MXitFyrsb8%3D (Pubitemid 29164651)
55. J Liu JE Schnitzer 1999 Analysis of lipids in caveolae Meth Mol Biol 116 61 72 1:CAS:528:DyaK1MXktVyitLs%3D
56. K Simons E Ikonen 1997 Functional rafts in cell membranes Nature 387 569 572 9177342 10.1038/42408 1:CAS:528:DyaK2sXktFCitrk%3D (Pubitemid 27248754)
57. JH Chidlow Jr WC Sessa 2010 Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation Cardiovasc Res 86 219 225 20202978 10.1093/cvr/cvq075 1:CAS:528:DC%2BC3cXlt1Glt7g%3D
58. PF Pilch RP Souto L Liu, et al. 2007 Cellular spelunking: exploring adipocyte caveolae J Lipid Res 48 2103 2111 17496267 10.1194/jlr.R700009-JLR200 1:CAS:528:DC%2BD2sXhtFemt7fE (Pubitemid 47529553)
59. N Oka M Yamamoto C Schwencke, et al. 1997 Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide J Biol Chem 272 33416 33421 9407137 10.1074/jbc.272.52.33416 1:CAS:528:DyaK1cXhtVahtg%3D%3D (Pubitemid 28023695)
60. R Goswami D Singh G Phillips J Kilkus G Dawson 2005 Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines J Neurosci Res 81 541 550 15968641 10.1002/jnr.20550 1:CAS:528: DC%2BD2MXnsVCjtLY%3D (Pubitemid 41297391)
61. L Li CH Ren SA Tahir C Ren TC Thompson 2003 Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A Mol Cell Biol 23 9389 9404 14645548 10.1128/MCB.23.24.9389-9404.2003 1:CAS:528:DC%2BD3sXpslGqur8%3D (Pubitemid 37499824)
62. S Le Lay TV Kurzchalia 2005 Getting rid of caveolins: phenotypes of caveolin-deficient animals Biochim Biophys Acta 1746 322 333 16019085 10.1016/j.bbamcr.2005.06.001 (Pubitemid 41815026)
63. JR Simard T Meshulam BK Pillai, et al. 2010 Caveolins sequester FA on the cytoplasmic leaflet of the plasma membrane, augment triglyceride formation, and protect cells from lipotoxicity J Lipid Res 51 914 922 20388923 10.1194/jlr.M900251 1:CAS:528:DC%2BC3cXltlWktr8%3D
64. K Hanada 2003 Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism Biochim Biophys Acta 1632 16 30 12782147 1:CAS:528: DC%2BD3sXktVyisbc%3D (Pubitemid 36628112)
65. JR Ussher TR Koves VJ Cadete, et al. 2010 Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole body oxygen consumption Diabetes 59 2453 2464 20522596 10.2337/db09-1293 1:CAS:528:DC%2BC3cXhsVGhs7nI
66. P Gual Y Le Marchand-Brustel JF Tanti 2005 Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 87 99 109 15733744 10.1016/j.biochi.2004.10.019 1:CAS:528:DC%2BD2MXhslCntLk%3D (Pubitemid 40298772)
67. 1101 J Biol Chem 279 45304 45307 15364919 10.1074/jbc.C400186200 1:CAS:528:DC%2BD2cXovVCgtbs%3D (Pubitemid 39491511)
68. SK Pinnamaneni RJ Southgate MA Febbraio MJ Watt 2006 Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro Diabetologia 49 3027 3037 17033839 10.1007/s00125-006-0427-9 1:CAS:528:DC%2BD28XhtFylt7bJ (Pubitemid 44730307)
69. WL Holland RA Miller ZV Wang, et al. 2011 Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin Nat Med 17 55 63 21186369 10.1038/nm.2277 1:CAS:528:DC%2BC3cXhs1Wis77E
70. A Dobrzyn M Zendzian-Piotrowska J Gorski 2004 Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat J Physiol Pharmacol 55 305 313 15213354 1:CAS:528: DC%2BD2cXmt1Cmu7w%3D (Pubitemid 38901964)
71. BT Bikman D Zheng MA Reed RC Hickner JA Houmard GL Dohm 2010 Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment Am J Physiol Regul Integr Comp Physiol 298 R1692 1699 20393162 10.1152/ajpregu.00190.2009 1:CAS:528:DC%2BC3cXnslCnsbw%3D
72. C Blazquez MJ Geelen G Velasco M Guzman 2001 The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes FEBS Lett 489 149 153 11165240 10.1016/S0014-5793(01)02089-0 1:CAS:528: DC%2BD3MXpsF2isQ%3D%3D (Pubitemid 32126399)
73. A Sriwijitkamol DK Coletta E Wajcberg, et al. 2007 Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study Diabetes 56 836 848 17327455 10.2337/db06-1119 1:CAS:528:DC%2BD2sXis12itbo%3D (Pubitemid 46348486)
74. GF Merrill EJ Kurth DG Hardie WW Winder 1997 AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle Am J Physiol 273 E1107 E1112 9435525 1:CAS:528:DyaK1cXjvFSmtw%3D%3D
75. C Henique A Mansouri G Fumey, et al. 2010 Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis J Biol Chem 285 36818 36827 20837491 10.1074/jbc.M110.170431 1:CAS:528:DC%2BC3cXhsVWgsrvK
76. CR Bruce AJ Hoy N Turner, et al. 2009 Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance Diabetes 58 550 558 19073774 10.2337/db08-1078 1:CAS:528:DC%2BD1MXjt1Wksb0%3D
77. E Coroneos M Martinez S McKenna M Kester 1995 Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation J Biol Chem 270 23305 23309 7559485 10.1074/jbc.270.40.23305 1:CAS:528:DyaK2MXos1eitLg%3D
78. KM Boini C Zhang M Xia JL Poklis PL Li 2010 Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high fat diet J Pharmacol Exp Ther 334 839 846 20543095 10.1124/jpet.110.168815 1:CAS:528: DC%2BC3cXhtFyksL%2FF
79. G Chocian A Chabowski M Zendzian-Piotrowska E Harasim B Lukaszuk J Gorski 2010 High fat diet induces ceramide and sphingomyelin formation in rat's liver nuclei Mol Cell Biochem 340 125 131 20174962 10.1007/s11010-010-0409-6 1:CAS:528:DC%2BC3cXntlGjsb8%3D
80. LF Ferreira JS Moylan LA Gilliam JD Smith M Nikolova-Karakashian MB Reid 2010 Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue Am J Physiol Cell Physiol 299 C552 C560 20519448 10.1152/ajpcell.00065.2010 1:CAS:528:DC%2BC3cXht1Wgu7rK
81. ML Wong B Xie N Beatini, et al. 2000 Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis Proc Natl Acad Sci USA 97 8681 8686 10890909 10.1073/pnas.150098097 1:CAS:528:DC%2BD3cXlt1Gnsb4%3D (Pubitemid 30639733)
82. GM Deevska KA Rozenova NV Giltiay, et al. 2009 Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice J Biol Chem 284 8359 8368 19074137 10.1074/jbc.M807800200 1:CAS:528:DC%2BD1MXjsVSisLo%3D
83. K Takeda S Akira 2005 Toll-like receptors in innate immunity Int Immunol 17 1 14 15585605 10.1093/intimm/dxh186 1:CAS:528:DC%2BD2cXhtVKru77P
84. DM Tsukumo MA Carvalho-Filho JB Carvalheira, et al. 2007 Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance Diabetes 56 1986 1998 17519423 10.2337/db06-1595 1:CAS:528: DC%2BD2sXos12qsrY%3D (Pubitemid 47195825)
85. JE Davis NK Gabler J Walker-Daniels ME Spurlock 2008 Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat Obes Silver Spring 16 1248 1255 10.1038/oby.2008.210 1:CAS:528:DC%2BD1cXmsFCgu7s%3D (Pubitemid 351770507)
86. RA Memon WM Holleran AH Moser, et al. 1998 Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin Arterioscler Thromb Vasc Biol 18 1257 1265 9714132 1:CAS:528:DyaK1cXlvVCgtb0%3D (Pubitemid 28376182)
87. M Langeveld KJ Ghauharali HP Sauerwein, et al. 2008 Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance J Clin Endocrinol Metab 93 845 851 18089699 10.1210/jc.2007-1702 1:CAS:528:DC%2BD1cXjsFynurs%3D (Pubitemid 351398562)
88. S Tagami J Inokuchi Ji K Kabayama, et al. 2002 Ganglioside GM3 participates in the pathological conditions of insulin resistance J Biol Chem 277 3085 3092 11707432 10.1074/jbc.M103705200 1:CAS:528:DC%2BD38XhtVaksrw%3D (Pubitemid 34953168)
89. K Kabayama T Sato F Kitamura, et al. 2005 TNFα-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3 Glycobiology 15 21 29 15306563 10.1093/glycob/cwh135 1:CAS:528:DC%2BD2cXhtVKqu7jF (Pubitemid 40202036)
90. JM Aerts R Ottenhoff AS Powlson, et al. 2007 Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity Diabetes 56 1341 1349 17287460 10.2337/db06-1619 1:CAS:528:DC%2BD2sXltlanuro%3D (Pubitemid 46715620)
91. T Yamashita A Hashiramoto M Haluzik, et al. 2003 Enhanced insulin sensitivity in mice lacking ganglioside GM3 Proc Natl Acad Sci USA 100 3445 3449 12629211 10.1073/pnas.0635898100 1:CAS:528:DC%2BD3sXisVCnurk%3D (Pubitemid 36356603)
92. H Zhao M Przybylska IH Wu, et al. 2007 Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes Diabetes 56 1210 1218 17470562 10.2337/db06-0719 1:CAS:528:DC%2BD2sXltlantb4%3D (Pubitemid 46715599)
93. K Kabayama T Sato K Saito, et al. 2007 Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance Proc Natl Acad Sci USA 104 13678 13683 17699617 10.1073/pnas. 0703650104 1:CAS:528:DC%2BD2sXpvVOjsLk%3D (Pubitemid 350003380)
94. S Yoshizumi S Suzuki M Hirai, et al. 2007 Increased hepatic expression of ganglioside-specific sialidase, NEU3, improves insulin sensitivity and glucose tolerance in mice Metabolism 56 420 429 17292733 10.1016/j.metabol.2006.10.027 1:CAS:528:DC%2BD2sXhs1CltL8%3D (Pubitemid 46209233)
95. T Sato Y Nihei M Nagafuku, et al. 2008 Circulating levels of ganglioside GM3 in metabolic syndrome: a pilot study Obes Res Clin Pract 2 231 238 10.1016/j.orcp.2008.06.001
96. C Yu Y Chen GW Cline, et al. 2002 Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle J Biol Chem 277 50230 50236 12006582 10.1074/jbc.M200958200 1:CAS:528:DC%2BD38Xps12gu7s%3D (Pubitemid 36042170)
97. M Skovbro M Baranowski C Skov-Jensen, et al. 2008 Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity Diabetologia 51 1253 1260 18458871 10.1007/s00125-008-1014-z 1:CAS:528:DC%2BD1cXmslWhtbk%3D
98. MJ Serlie AJ Meijer JE Groener, et al. 2007 Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects J Clin Endocrinol Metab 92 1524 1529 17264178 10.1210/jc.2006-2347 1:CAS:528:DC%2BD2sXksVSrtb0%3D (Pubitemid 46556434)
99. K Minehira SG Young CJ Villanueva, et al. 2008 Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice J Lipid Res 49 2038 2044 18515909 10.1194/jlr.M800248-JLR200 1:CAS:528:DC%2BD1cXhtVKntbvP
100. C Pavoine F Pecker 2009 Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology Cardiovasc Res 82 175 183 19176603 10.1093/cvr/cvp030 1:CAS:528:DC%2BD1MXksVakt70%3D